Research | OneLook Acronym Finder |
Serial Number | 75754754 |
Registration Number | 2593415 |
Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
Cancellation Code | 2 |
Attorney Name | Jane Ungaro |
Law Office Assigned | L50 |
Employee Name | CASE, LEIGH CAROLINE |
1999-07-20 | Application Filed |
2002-04-23 | Published for Opposition |
2002-07-16 | Trademark Registered |
2007-12-05 | Location: SCANNING ON DEMAND |
2009-04-18 | Cancelled |
2009-04-18 | Status: Dead/Cancelled |
2018-07-08 | Transaction Date |
Owner: | Powderject Research Limited |
Address | 4 Robert Robinson Avenue The Oxford Science Park Oxfordshire OX4 4G GB GB2 |
Legal Entity Type | Corporation |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | pharmaceutical preparations for human and veterinary use for the prevention and treatment of cardiovascular, dental and periodontal, dermatologic, endocrine and metabolic, gastrointestinal, genetic, hematologic, hepatic, immunologic, lymphatic, osteologic, neurologic, ophthalmic, psychiatric, reproductive system, respiratory tract, and renal and urinary tract diseases and disorders; pharmaceutical preparations for human and veterinary use, namely, adjuvants, analgesics, antibiotics, anti-cancer preparations, anti-infectives, anti-parasitics, antivirals, anti-inflammatories, antihistamines, anti-migraines, vaccines, anesthetics, insulin, hormones, steroids, hormone antagonists, enzyme inhibitors; and diagnostic preparations for medical use |
Description | Date | Event Coding |
---|---|---|
ASSIGNED TO EXAMINER | 1999-10-26 | 1 DOCK D:Assigned to Examiner |
ASSIGNED TO EXAMINER | 1999-10-27 | 2 DOCK D:Assigned to Examiner |
NON-FINAL ACTION MAILED | 1999-11-08 | 3 CNRT F:First Action |
Sec. 1(B) CLAIM DELETED | 2000-07-05 | 4 1.BD I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2000-07-05 | 5 CRFA I:Incoming Correspondence |
FINAL REFUSAL MAILED | 2001-01-12 | 6 CNFR O:Outgoing Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-05-29 | 7 CRFA I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2001-09-19 | 8 CNSA O:Outgoing Correspondence |
Sec. 1(B) CLAIM DELETED | 2001-05-29 | 9 1.BD I:Incoming Correspondence |
NOTICE OF PUBLICATION | 2002-04-03 | 10 NPUB O:Outgoing Correspondence |
PUBLISHED FOR OPPOSITION | 2002-04-23 | 11 PUBO A:Allowance for Publication |
REGISTERED-PRINCIPAL REGISTER | 2002-07-16 | 12 R.PR A:Allowance for Publication |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2006-12-14 | 13 TCCA I:Incoming Correspondence |
CASE FILE IN TICRS | 2007-12-05 | 14 CFIT O:Outgoing Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2008-05-09 | 15 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2008-05-09 | 16 ARAA I:Incoming Correspondence |
CANCELLED SEC. 8 (6-YR) | 2009-04-18 | 17 C8.. O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.